Privacy preferences
Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.
  • Forum
  • Premium
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • FemmeBreaking barriers and building confidence in investing
  • Learn about investing
    • Analysis SchoolLearn how to read and understand stock analysis
    • Investing SchoolGuides and lessons to grow your investing knowledge
    • Portfolio buildersInvesting knowledge for every level, from first steps to advanced portfolio strategies.
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Insider TransactionsTrack buying and selling activity by company insiders
    • Short SellingSee which listed companies have disclosed short interest
    • Virtual Analyst ChatAsk questions and get instant AI-powered investment insights
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Medclair receives a new order worth approximately 12 MSEK in the UK

MCLRRegulatory press release20.08.2026 klo 09.32
Download the release

Medclair has received a new order from a leading player in the recycling sector. The order value amounts to approximately 12 MSEK and pertains to the UK market. Parts of the order include an installation in Scotland, which means that Medclair is establishing itself in a new geographical market.

Through the new order, Medclair continues to gain ground in the recycling sector, a segment where the company has built a stable and growing customer base in several European countries in recent years. With the installation in Scotland, Medclair's technology for the recycling sector is now in place in England, Scotland, Ireland, Belgium, France, Denmark, and Sweden.

The order confirms the demand Medclair sees in the recycling segment and strengthens the company's position as an established provider of solutions for nitrous oxide destruction for players in waste management and recycling in the UK and the rest of Europe.

"Taking on Scotland as a new market is clear proof that our technology for safe and sustainable nitrous oxide management is in broad demand within the recycling sector, both in the UK and in the rest of Europe. Recycling has in a short time developed into one of our most important growth areas, and together with dental and healthcare, we now have three stable business areas – industry, dental, and healthcare – to rely on in our continued expansion," says Jonas Lundh, CEO of Medclair.

Medclair's three business areas – industry, dental, and healthcare – provide the company with a broader revenue base and reduce its dependence on individual segments or markets. The recycling sector, which is part of the industry business area, has grown over the past year to become a significant part of the order intake and contributes to spreading the company's geographical and commercial risk.

Jonas Lundh
CEO
Medclair AB

For further information, please contact:
Jonas Lundh, Medclair AB (publ), Phone: +46 76 193 90 90, Email: jonas.lundh@medclair.com

About Us
Medclair is a Swedish cleantech company and a leader in safe and sustainable nitrous oxide management. With operations in twenty countries, Medclair provides innovative solutions that significantly reduce the climate impact of nitrous oxide while improving workplace safety.

The company is listed on NGM Nordic SME. For more information, please visit www.medclair.com.

This information is information that Medclair is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 2026-08-20 08:32 CEST.

Attachments
Medclair receives a new order worth approximately 12 MSEK in the UK